Related Experiment Videos
Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes
Diana M Stafforini1, Thomas M McIntyre, Guy A Zimmerman
1Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112-5550, USA. diana.stafforini@hci.utah.edu
Critical Reviews in Clinical Laboratory Sciences
|January 8, 2004
Summary
Platelet-activating factor (PAF) is a key signaling molecule involved in inflammation and other physiological processes. Its production and inactivation pathways are crucial for understanding inflammatory diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Platelet-activating factor (PAF) is a potent phospholipid mediator.
- PAF influences diverse physiological and pathological processes, including inflammation, wound healing, and apoptosis.
- PAF signaling involves MAP kinase pathways modulating PAF biosynthesis enzymes.
Purpose of the Study:
- To review the role of PAF and its analogs in biological processes.
- To highlight the signaling pathways and enzymes involved in PAF metabolism.
- To discuss the implications of PAF signaling in inflammatory diseases.
Main Methods:
- Literature review of PAF biosynthesis, signaling, and inactivation.
- Analysis of the role of MAP kinase pathways in PAF production.
- Examination of PAF receptor interactions and downstream signaling.
Main Results:
- PAF and "PAF-like" lipids act via the PAF receptor, a G protein-coupled receptor.
- MAP kinase pathways modulate key enzymes in PAF remodeling and biosynthesis.
- PAF acetylhydrolases inactivate PAF superfamily members, terminating signaling.
Conclusions:
- Dysregulated PAF signaling contributes to inflammatory diseases.
- Understanding PAF metabolism and signaling is critical for therapeutic interventions.
- PAF and its analogs represent a significant superfamily of bioactive lipids.